At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is $21.31M, above the global median of $18.58M
- FinancialsAltman Z-Score 2.07: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
512.64MUSDvs all stocks (USD)
Revenue (TTM)
325.38MUSDvs all stocks (USD)
Profit Margin
-10.12%vs Medical Instruments & Supplies peers
Beta
0.3040xvs all stocks
52-Week Change
-0.81%vs all stocks
Forward Annual Dividend Yield
0.00%vs all stocks
Market Capitalization
512.64MUSDvs all stocks (USD)
Enterprise Value
496.77MUSDvs all stocks (USD)
Forward P/E
-109.11xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.60xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.20xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.53xvs Medical Instruments & Supplies peers
Gross Margin
54.01%vs Medical Instruments & Supplies peers
Profit Margin
-10.12%vs Medical Instruments & Supplies peers
Operating Margin
-7.81%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-5.15%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-19.21%vs Medical Instruments & Supplies peers
Revenue (TTM)
325.38MUSDvs all stocks (USD)
Revenue per Share (TTM)
7.80USDUpdated Oct 26, 2026Quarterly Revenue Growth
6.90%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
179.88MUSDvs all stocks (USD)
EBITDA (TTM)
18.22MUSDvs all stocks (USD)
Net Income (TTM)
-32.94MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
8.05%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
3.67MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
21.31MUSDvs all stocks (USD)
Forward Annual Dividend Yield
0.00%vs all stocks
Trailing Annual Dividend Rate
0.00USDUpdated Oct 26, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
320.17MUSDFY2026 · May 31, 2026Cost of Goods Sold
145.28MUSDFY2026 · May 31, 2026Gross Profit
174.89MUSDFY2026 · May 31, 2026Operating Income
-22.33MUSDvs all stocks (USD)
Pre-tax Income
-36.30MUSDFY2026 · May 31, 2026Income Tax Expense
442.00KUSDFY2026 · May 31, 2026Net Income
-36.74MUSDFY2026 · May 31, 2026EBIT
-22.33MUSDFY2026 · May 31, 2026EBITDA (Income Statement)
18.22MUSDFY2026 · May 31, 2026Research & Development
29.45MUSDFY2026 · May 31, 2026Selling, General & Administrative
157.09MUSDFY2026 · May 31, 2026EPS (Basic)
-0.8800USDFY2026 · May 31, 2026EPS (Diluted)
-0.8800USDFY2026 · May 31, 2026Basic Shares Outstanding
41.53MSharesFY2026 · May 31, 2026Diluted Shares Outstanding
41.53MSharesFY2026 · May 31, 2026Net Income from Continuing Operations
-36.74MUSDFY2026 · May 31, 2026Operating Cash Flow
2.59MUSDFY2026 · May 31, 2026Free Cash Flow
13.00KUSDFY2026 · May 31, 2026Cash & Cash Equivalents (End of Period)
53.86MUSDFY2026 · May 31, 2026Income Tax Paid
405.00KUSDFY2026 · May 31, 2026Interest Paid
426.00KUSDFY2026 · May 31, 2026Starting Profit (CF Statement)
-36.74MUSDFY2026 · May 31, 2026Depreciation & Amortization
22.95MUSDFY2026 · May 31, 2026Deferred Taxes (CF)
143.00KUSDFY2026 · May 31, 2026Stock-based Compensation
13.96MUSDFY2026 · May 31, 2026Other Non-cash Items
3.81MUSDFY2026 · May 31, 2026Change in Accounts Receivable (CF)
-5.75MUSDFY2026 · May 31, 2026Change in Accounts Payable (CF)
-5.83MUSDFY2026 · May 31, 2026Change in Other Assets/Liabilities
10.05MUSDFY2026 · May 31, 2026Capital Expenditures
-2.58MUSDFY2026 · May 31, 2026Net Intangibles (CF)
0.00USDFY2026 · May 31, 2026Other Investing Activity
-3.37MUSDFY2026 · May 31, 2026Net Investing Cash Flow
-5.95MUSDFY2026 · May 31, 2026Long-term Debt Payments
0.00USDFY2026 · May 31, 2026Common Stock Repurchase
0.00USDFY2026 · May 31, 2026Other Financing Charges
-375.00KUSDFY2026 · May 31, 2026Net Financing Cash Flow
-375.00KUSDFY2026 · May 31, 2026Shares Outstanding
41.70MSharesUpdated Oct 26, 2026Float Shares
32.73MSharesUpdated Oct 26, 2026Shares Short
1.29MSharesUpdated Oct 26, 2026Short Ratio
2.65daysvs all stocks
Short % of Shares Outstanding
3.32%vs all stocks
% Held by Insiders
13.09%vs all stocks
% Held by Institutions
92.66%vs all stocks
Total Cash (MRQ)
33.97MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.8080USDUpdated Oct 26, 2026Total Debt (MRQ)
10.74MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0655xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.40xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
3.87USDUpdated Oct 26, 2026Total Assets
267.16MUSDvs all stocks (USD)
Total Current Assets
163.39MUSDFY2026 · May 31, 2026Total Liabilities
96.34MUSDFY2026 · May 31, 2026Total Non-current Assets
103.77MUSDFY2026 · May 31, 2026Total Non-current Liabilities
21.62MUSDFY2026 · May 31, 2026Total Current Liabilities
74.72MUSDFY2026 · May 31, 2026Cash & Cash Equivalents
53.86MUSDFY2026 · May 31, 2026Accounts Receivable
48.33MUSDFY2026 · May 31, 2026Inventory
52.44MUSDFY2026 · May 31, 2026Accounts Payable
31.51MUSDFY2026 · May 31, 2026Deferred Revenue
288.00KUSDFY2026 · May 31, 2026Other Current Liabilities
4.29MUSDFY2026 · May 31, 2026Other Non-current Liabilities
16.30MUSDFY2026 · May 31, 2026Common Stock (Book)
387.00KUSDFY2026 · May 31, 2026Retained Earnings
-465.94MUSDFY2026 · May 31, 2026Total Shareholders' Equity
170.82MUSDvs all stocks (USD)
Treasury Stock
7.38MUSDFY2026 · May 31, 202652-Week Low
9.39USDUpdated Oct 26, 202652-Week High
16.29USDUpdated Oct 26, 202652-Week Change
-0.81%vs all stocks
Beta
0.3040xvs all stocks
50-Day MA
14.55USDUpdated Oct 26, 2026200-Day MA
12.42USDUpdated Oct 26, 2026Avg 10-Day Volume
1.03MSharesUpdated Oct 26, 2026Avg 30-Day Volume
911.80KSharesUpdated Oct 26, 2026Diluted EPS (TTM)
-0.7800USDUpdated Oct 26, 2026Other Income / Expense
-13.67MUSDFY2026 · May 31, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.54Profit Margin: -0.10
Financial Health
Altman Z-Score 2.07: grey zoneSignificant
Altman Z-Score: 2.07
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $21.31M, above the global median of $18.58MNotable
Levered free cash flow (USD): 21,310,376Global Median: 18,579,867.004
Companies that share the same coordination system — how they create, deliver, or capture value.
Yantai Longyuan Power Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Xiasha Precision Engineering Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Healthcare Co Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
PT Semen Indonesia (Persero) Tbk
Tier 1ProductionThroughput-Bound ConversionFlowRule
IFB Industries Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Soling Industrial Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Grand Industrial Holding Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Stx Engine Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Ningbo Shimao Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Luoyang North Glass Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule